rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

ProMIS Neurosciences Inc. - Common Shares

PMN · Nasdaq

Health CareBiotechnologyNot moving yet

PMN stood above a rising 150-day average in 19 of the last 52 weekly readings, and has been out of that trend for the last 6 weeks. It is 24.9% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−12 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 6
Industry in uptrend
18% -12 in 4 wk
Insider buys, 12 months
$17.5M
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
27 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 19 of 52 weeks.

22 Apr – 21 Oct
16%27%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$16.4MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months9
Sale orders, 12 months0
Buyers · sellers5 · 0
WhoDidSharesTraded
Johanne KaplanChief Development Officerbought2,280at $13.305 Aug 2026filed 7 Aug 2026
Patrick D. KirwinDirectorbought4,000at $11.3322 Apr 2026filed 23 Apr 2026
Eugene WilliamsDirectorbought2,000at $24.405 Mar 2026filed 6 Mar 2026
Eugene WilliamsDirectorbought2,000at $24.004 Mar 2026filed 4 Mar 2026
Eugene WilliamsDirectorbought1,000at $21.893 Mar 2026filed 4 Mar 2026
Eugene WilliamsDirectorbought1,000at $22.532 Mar 2026filed 4 Mar 2026
Johanne KaplanChief Development Officerbought1,629at $15.3519 Feb 2026filed 23 Feb 2026
Abg Management Ltd.10% ownerbought700,741at $12.133 Feb 2026filed 5 Feb 2026
Abg Management Ltd.10% ownerbought700,7413 Feb 2026filed 5 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders27+2 on the quarter
New · exited5 · 3
Reported value$84.3M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Jupiter Topco LLCnew · filed 14 Aug 20261,292,757$17.0M+1,292,757
Deep Track Capital, LPunchanged · filed 14 Aug 2026835,655$11.0M00.0%
WELLINGTON MANAGEMENT GROUP LLPunchanged · filed 14 Aug 2026696,378$9.2M00.0%
Ally Bridge Group (NY) LLCadded · filed 14 Aug 2026620,319$8.2M+206,100+49.8%
Trails Edge Capital Partners, LPunchanged · filed 14 Aug 2026557,103$7.3M00.0%
Woodline Partners LPadded · filed 14 Aug 2026441,911$5.8M+46,616+11.8%
Yu Fanunchanged · filed 14 Aug 2026329,760$4.3M00.0%
SPHERA FUNDS MANAGEMENT LTD.unchanged · filed 14 Aug 2026325,591$4.3M00.0%
Squadron Capital Management LLCunchanged · filed 14 Aug 2026324,977$4.3M00.0%
Ikarian Capital, LLCadded · filed 14 Aug 2026205,000$2.7M+150,000+272.7%
31 Mar 2023 – 30 Jun 2026
91826Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Ivana Rubino Company insiderChief Commercial Officer · last 5 Oct 20260 · 0
Johanne Kaplan Company insiderChief Development Officer · last 5 Aug 20262 · 0
Eugene Williams Company insiderDirector · last 20 May 20269 · 0
Josh Mandel-Brehm Company insiderDirector · last 20 May 20260 · 0
Madge K. Shafmaster Company insiderDirector · last 20 May 20263 · 0
Max A. Milbury Company insiderPrincipal Accounting Officer · last 20 May 20261 · 0
Neil Cashman Company insiderChief Scientific Officer · last 20 May 20261 · 0
Neil K. Warma Company insiderChief Executive Officer · last 20 May 20260 · 0
Slanix Paul Alex Company insiderDirector · last 20 May 20260 · 0
William W. Wyman Company insiderDirector · last 20 May 20260 · 0
Patrick D. Kirwin Company insiderDirector · last 22 Apr 20266 · 0
ABG Management Ltd. Company insider10% owner · last 3 Feb 20261 · 0

Same industry

MRNA ModernaLeading+168%
ENTX Entera BioLeading+53%
XNCR XencorLeading+41%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 25 Mar 2026317%
Cash and equivalentsFY 2025 · to 31 Dec 2025$6.1M

Analyst forecasts

No analyst forecasts yet.